Literature DB >> 11400122

Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer.

J E Curran1, R A Lea, S Rutherford, S R Weinstein, L R Griffiths.   

Abstract

We have utilized a cross-sectional association approach to investigate sporadic breast cancer. Polymorphisms in 2 candidate genes, ESRalpha and GRL, were examined in an unrelated breast cancer-affected and age-matched control population. Several polymorphic regions within the ESRalpha gene have been identified, and some alleles of these polymorphisms have been found to occur at increased levels in breast-cancer patients. Additionally, variations in GRL have the potential to disrupt cell transcription and may be associated with cancer formation. We analyzed 3 polymorphisms, from codons 10 (TCT to TCC), 325 (CCC to CCG) and 594 (ACA to ACG) of ESRalpha, and a highly polymorphic dinucleotide repeat, D5S207, located within 200 kb of the GRL. When allelic frequencies of the codon 594 (exon 8) ESR polymorphism were compared between affected and unaffected populations, a significant difference was observed (p = 0.005). Results from the D5S207 dinucleotide repeat located near GRL also indicated a significant difference between the tested case and control populations (p = 0.001). Allelic frequencies of the codon 10 and codon 325 ESR polymorphisms were not significantly different between populations (p = 0.152 and 0.181, respectively). Our results indicate that specific alleles of the ESR gene (alpha subtype) and a marker for the GRL gene locus are associated with sporadic breast-cancer development in the tested Caucasian population and justify further investigation of the role of these and other nuclear steroid receptors in the etiology of breast cancer. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11400122     DOI: 10.1002/1097-0215(20010720)95:4<271::aid-ijc1046>3.0.co;2-d

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  Genetics of menstrual migraine: the molecular evidence.

Authors:  Natalie Colson; Francesca Fernandez; Lyn Griffiths
Journal:  Curr Pain Headache Rep       Date:  2010-10

2.  Genetic variants of EGFR (142285G>A) and ESR1 (2014G>A) gene polymorphisms and risk of breast cancer.

Authors:  Ranbir Chander Sobti; Marjan Askari; Mohsen Nikbakht; Neha Singh; Suresh C Sharma; Abayneh Munshea Abitew
Journal:  Mol Cell Biochem       Date:  2012-07-19       Impact factor: 3.396

3.  Association of estrogen receptor-α A908G (K303R) mutation with breast cancer risk.

Authors:  Sakineh Abbasi; Mina Rasouli; Mehrnaz Nouri; Samira Kalbasi
Journal:  Int J Clin Exp Med       Date:  2012-11-18

4.  Predictive index for the onset of medication overuse headache in migraine patients.

Authors:  T Onaya; M Ishii; H Katoh; S Shimizu; H Kasai; M Kawamura; Y Kiuchi
Journal:  Neurol Sci       Date:  2013-01       Impact factor: 3.307

5.  Negative predictors of clinical response to triptans in patients with migraine.

Authors:  M Ishii; Y Sakairi; H Hara; A Imagawa; S Shimizu; J Takahashi; A Nagamine; Y Naito; Y Masuda; S Usami; Y Kiuchi
Journal:  Neurol Sci       Date:  2011-08-06       Impact factor: 3.307

6.  Estrogen receptor genes variations and breast cancer risk in Iran.

Authors:  Sakineh Abbasi; Mehrnaz Nouri; Cyrus Azimi
Journal:  Int J Clin Exp Med       Date:  2012-08-25

7.  Role of genetic polymorphism of estrogen receptor-alpha gene and risk of prostate cancer in north Indian population.

Authors:  Lipsy Gupta; Hitender Thakur; Ranbir C Sobti; Amlesh Seth; Sharwan K Singh
Journal:  Mol Cell Biochem       Date:  2009-11-11       Impact factor: 3.396

8.  Estrogen receptor-beta gene polymorphism in women with breast cancer at the Imam Khomeini Hospital Complex, Iran.

Authors:  Sakineh Abbasi
Journal:  BMC Med Genet       Date:  2010-07-07       Impact factor: 2.103

9.  The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups.

Authors:  Natalie J Colson; Rod A Lea; Sharon Quinlan; John MacMillan; Lyn R Griffiths
Journal:  Neurogenetics       Date:  2004-05-07       Impact factor: 2.660

10.  Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in Tunisia.

Authors:  Imen Kallel; Maha Rebai; Abdelmajid Khabir; Nadir R Farid; Ahmed Rebaï
Journal:  J Biomed Biotechnol       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.